Serum biochemical markers for brain damage in children with emphasis on mild head injury

Pediatric Neurosurgery

Volumn 46, Issue 2, 2010, Pages 82-88

  Menascu, Shay ^a,d   Brezner, Amichai ^a   Tshechmer, Shany M ^b   Rumeny, Peter G ^c  

^a TEL AVIV UNIVERSITY   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^c UNIVERSITY OF TORONTO   (Canada)

^d NONE   (Israel)

Author keywords

Glial fibrillary acidic protein; Mild head trauma; Myelin basic protein; Neuron specific enolase; S100 calcium binding protein B

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; MYELIN BASIC PROTEIN; NEURON SPECIFIC ENOLASE; PROTEIN S100B;

CHILD; CLINICAL FEATURE; COGNITION; HUMAN; HYPOXEMIA; NEUROPATHOLOGY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; REVIEW; TRAUMATIC BRAIN INJURY;

ASTROCYTES; BIOLOGICAL MARKERS; BRAIN INJURIES; CHILD; CRANIOCEREBRAL TRAUMA; HUMANS; MYELIN SHEATH;

EID: 77954685808     PISSN: 10162291     EISSN: None     Source Type: Journal    
DOI: 10.1159/000319004     Document Type: Review

References (44)

1. Satz P, Zaucha K, McCleary C, et al: Mild head injury in children and adolescents: a review of studies (1970-1995). Psychol Bull 1997; 122: 107-131.
2. Bijur OE, Haslum M, Golding J: Cognitive outcomes of multiple mild head injuries in children. J Dev Behav Pediatr 1996; 17: 143-147.
3. Zhang L, Yang KH, King AI: A proposed injury threshold for mild traumatic brain injury. J Biomech Eng 2004; 126: 226-236. (Pubitemid 38621136)
4. Mild Traumatic Brain Injury Committee of the Head Injury Interdisciplinary Special Interest Group of the American Congress of Rehabilitation Medicine: Definition of mild traumatic brain injury. J Head Trauma Rehabil 1993; 8: 86-87.
5. Korinthenberg R, Schreck J, Weser J, et al: Post-traumatic syndrome after minor head injury cannot be predicted by neurological investigations. Brain Dev 2004; 26: 113-117.
6. Beers SR, Berger RP, Adelson PD: Neurocognitive outcome and serum biomarkers in inflicted versus non-inflicted traumatic brain injury in young children. J Neurotrauma 2007; 24: 97-105.
7. Fletcher JM, Levin HS, Lachar D, et al: Behavioral outcomes after pediatric closed head injury: relationships with age, severity, and lesion size. J Child Neurol 1996; 11: 283-290.
8. Hahn YS, Chyung C, Barthel MJ, Bailes J, Flannery AM, McLone DG: Head injuries in children under 36 months of age: demography and outcome. Childs Nerv Syst 1988; 4: 34-40.
9. Keel M, Trentz O: Pathophysiology of polytrauma. Injury 2005; 36: 691-709.
10. Bazarian JJ, McClung J, Shah MN: Mild traumatic brain injury in the United States, 1998-2000. Brain Inj 2005; 19: 85-91. (Pubitemid 40259746)
11. Biegon A, Fry PA, Paden CM, et al: Dynamic changes in N-methyl-D -aspartate receptors after closed head injury in mice: implications for treatment of neurological and cognitive deficits. Proc Natl Acad Sci USA 2004; 101: 5117-5122.
12. Jimi T, Wakayama Y, Shibuya S, Nakata H, Tomaru T, Takahashi Y, et al: High levels of nervous system-specific proteins in cerebrospinal fluid. Clin Chim Acta 1992; 211: 37-46.
13. Graeber GM, Clagett GP, Wolf RE, Cafferty PJ, Harmon JW, Rich NM: Alterations in serum creatine kinase and lactate dehydrogenase: association with abdominal aortic surgery, myocardial infarction and bowel necrosis. Chest 1990; 97: 521-527.
14. Elson LM, Ward CC: Mechanisms and pathophysiology of mild head injury. Semin Neurol 1994; 14: 8-18.
15. Ergün R, Bostanci U, Akdemir G, Beskonakli E, Kaptanoglu E, Gürsoy F, Taskin Y: Prognostic value of serum neuron-specific enolase levels after head injury. Neurol Res 1998; 20: 418-420.
16. Skogseid IM, Nordby HK, Urdal P, Paus E, Lilleaas F: Increased serum creatine kinase BB and neuron-specific enolase following head injury indicates brain damage. Acta Neurochir (Wien) 1992; 115: 106-111.
17. Stålnacke BM, Björnstig U, Karlsson K, Sojka P: One-year follow-up of mild traumatic brain injury: post-concussion symptoms, disabilities and life satisfaction in relation to serum levels of S-100B and neurone-specific enolase in acute phase. J Rehabil Med 2005; 37: 300-305.
18. Missler U, Wiesmann M, Wittmann G, Magerkurth O, Hagenström H: Measurement of glial fibrillary acidic protein in human blood: analytic method and preliminary clinical results. Clin Chem 1999; 45: 138-141.
19. Herrmann M, Ehrenreich H: Brain-derived proteins as markers of acute stroke: their relation to pathophysiology, outcome prediction and neuroprotective drug monitoring. Restor Neurol Neurosci 2003; 21: 177-190.
20. Ross SE, Leipold C, Terregino C, O'Malley KF: Efficacy of the motor component of the Glasgow Coma Scale in trauma triage. J Trauma 1998;45:42-44.
21. Stranjulis G, Korfias S, Papapetrou C: Elevated serum S100B protein as a predictor of failure to short-term return to work or activities after mild head injury. J Neurotrauma 2004; 21: 1070-1075.
22. Schmitt B, Bauersfeld U, Schmid ER, Tuchschmid P, Molinari L, Fanconi S, Bandtlow C: Serum and CSF levels of neuron-specific enolase (NSE) in cardiac surgery with cardiopulmonary bypass: a marker of brain injury? Brain Dev 1998; 20: 536-539.
23. Lumpkins KM, Bochicchio GV, Keledjian K, Simard JM, McCunn M, Scalea T: Glial fibrillary acidic protein is highly correlated with brain injury. J Trauma 2008; 65: 778-782.
24. Pelinka LE: Serum markers of severe traumatic brain injury. Indian J Crit Care Med 2004; 8: 190-193.
25. Carter BG, Butt W: A prospective study of outcome predictors after severe brain injury in children. Intensive Care Med 2005; 31: 840-845.
26. Berger RP, Beers SR, Richichi R, Wiesman D, Adelson PD: Serum biomarker concentrations and outcome after pediatric traumatic brain injury. J Neurotrauma 2007; 24: 1793-1801.
27. Spinella PC, Dominguez T, Drott HR, et al: S-100β protein serum levels in healthy children and its association with outcome in pediatric traumatic brain injury. Crit Care Med 2003; 31: 939-945.
28. Jackson RG, Samra GS, Radcliffe J, Clark GH, Price CP: The early fall in levels of S-100B in traumatic brain injury. Clin Chem Lab Med 2000; 38: 1165-1167.
29. Herrmann M, Curio N, Jost S, Wallesch CW: Protein S-100B and neuron-specific enolase as early neurobiochemical markers of the severity of traumatic brain injury. Restor Neurol Neurosci 1999; 14: 109-114.
30. Jackson RG, Samra GS: Differences in the release of S100 protein during cardiopulmonary bypass. Anaesthesia 2002; 57: 91-92.
31. Svenmarker S, Sandström E, Karlsson T, Aberg T: Is there an association between release of protein S100B during cardiopulmonary bypass and memory disturbances? Scand Cardiovasc J 2002; 36: 117-122.
32. de Kruijk JR, Leffers P, Menheere PP, Meerhoff S, Twijnstra A: S-100B and neuron-specific enolase in serum of mild traumatic brain injury patients: a comparison with healthy controls. Acta Neurol Scand 2001; 103: 175-179.
33. Newcombe F, Rabbitt P, Briggs M: Minor head injury: pathophysiological or iatrogenic sequelae? J Neurol Neurosurg Psychiatry 1994; 57: 709-716.
34. Crooks DA: The pathological concept of diffuse axonal injury in head trauma. J Pathol 1991; 165: 5-10.
35. Missler M, Eins S, Böttcher H, Wolff JR: Postnatal development of glial fibrillary acidic protein, vimentin and S100 protein in monkey visual cortex: evidence for a transient reduction of GFAP immunoreactivity. Dev Brain Res 1994; 82: 103-117.
36. Adelson PD, Ragheb J, Kanev P, Brockmeyer D, Beers SR, Brown SD, Cassidy LD, Chang Y, Levin H: Phase II clinical trial of moderate hypothermia after severe traumatic brain injury in children. Neurosurgery 2005; 56: 740-754.
37. Ingebrigtsen T, Romner B: Biochemical serum markers of traumatic brain injury. J Trauma 2002; 52: 798-808.
38. Topal NB, Hakyemez B, Erdogan C: MR imaging in the detection of diffuse axonal injury with mild traumatic brain injury. Neurol Res 2008; 7: 41-43.
39. Keenan HT, Runyan DK, Nocera M: Child outcomes and family characteristics 1 year after severe inflicted or noninflicted traumatic brain injury. Pediatrics 2006; 117: 317-324.
40. Starling SP, Patel S, Burke BL, Sirotnak AP, Stronks S, Rosquist P: Analysis of perpetrator admissions to inflicted traumatic brain injury in children. Arch Pediatr Adolesc Med 2004; 158: 454-458.
41. Geddes JF, Hackshaw AK, Vowles GH, Nickols CD, Whitwell HL: Neuropathology of inflicted head injury in children: patterns of brain damage. Brain 2004; 124: 1290-1298.
42. Berger R, Adelson P, Dulani T, Pierce M, Cassidy L, Kochanek P: Serum neuron-specific enolase, S100B and myelin basic protein concentrations after inflicted and non-inflicted traumatic brain injury in children. J Neurosurg Pediatr 2005; 103: 61-68.
43. Ashraf S, Bhattacharya K, Zacharias S, Kaul P, Kay PH, Watterson KG: Serum S100β release after coronary artery bypass grafting: roller versus centrifugal pump. Ann Thorac Surg 1998; 66: 1958-1962.
44. Townend W, Dibble C, Abid K, Vail A, Sherwood R, Lecky F: Rapid elimination of protein S-100B from serum after minor head trauma. J Neurotrauma 2006; 23: 149-155.